A Study to Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With Chemotherapy

Clinical trial NCT06528093 · TERMINATED

Trial details

NCT number: NCT06528093
Sponsor: Boehringer Ingelheim
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreatic Ductal Adenocarcinoma

Start date: 2024-10-16
Primary completion: 2025-03-19
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.